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Correlation of Age and Incidence of Pancreatic Exocrine Nodular Hyperplasia
in the Dog
S. J. NEWMAN,1 J. M. STEINER, K. WOOSLEY, L. BARTON,

AND

D. A. WILLIAMS

Abstract. The purpose of this study was to determine the prevalence of pancreatic nodular hyperplasia
(NH) and its relation to age in the dog. A total of 101 dogs were enrolled. The pancreas was evaluated by
histology and hyperplastic lesions were detected and scored. Age was recorded from the medical records.
Correlation of age with inflammation and presence of hyperplastic lesions was evaluated. Of the 101 dogs, 81
(80.2%) had evidence of NH. Twenty-five of the 101 dogs did not have evidence of pancreatic inflammation,
necrosis, and/or fibrosis, 17 (68.0%) of which had evidence of NH. Mean ⫾ SD age in dogs with NH was
significantly higher compared with dogs without NH (9.5 ⫾ 3.4 years versus 3.4 ⫾ 3.3; P-value ⬍ 0.0001).
We conclude that NH is a common pathologic lesion in dogs and shows a positive correlation with age regardless
of the presence or absence of pancreatic inflammation, necrosis, or fibrosis.
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Exocrine pancreatic nodular hyperplasia (NH) has been
reported in cattle, cats, and dogs.5,7 The condition has been
considered an incidental finding.2,5 Several authors have suggested that the nodules may represent age-related hyperplastic foci rather than either a response to previous injury or
an early stage of progressive pancreatic epithelial neoplasia.5
However, it has been speculated that, in young animals, NH
may indicate antecedent inflammation or scarring.5 Hyperplasia may be manifested as a solitary nodule or, more commonly, as multiple, small, white to tan, well-circumscribed
nodules.5 Microscopic lesions are typically nonencapsulated
and minimally or noncompressive of adjacent pancreatic parenchyma.5 Ductular hyperplasia is an uncommon lesion but
may accompany the more common exocrine pancreatic acinar NH.5 NH can be distinguished from pancreatic adenoma
on light microscopy by the multiplicity, the smaller size, the
lack of a capsule, and the close resemblance with normal
exocrine pancreatic tissue.5
The goal of this study was to assess numerous pancreatic
sections from dogs presented for necropsy to determine the
1 Present address: Department of Pathology, College of
Veterinary Medicine, University of Tennessee, Knoxville,
TN.
Presented in part at the American College of Veterinary
Internal Medicine Forum, Minneapolis, MN, June, 2004.

incidence of pancreatic NH, its association with other pancreatic pathology, and any association with age.
A total of 101 pancreata from consecutive dogs presented
for routine necropsy examination to the Pathology Service
at the Animal Medical Center (AMC) were enrolled into the
study. Inclusion criteria consisted of having an antemortem
serum sample collected and having the pancreas removed in
its entirety within 6 hours of death. Fixation of the pancreas
in 10% buffered formalin within the 6-hour period was done
in order to eliminate any postmortem degeneration/autolysis
of the pancreatic tissue. The right limb of the pancreas was
identified with a suture at the time of removal. Pancreata
were sectioned every 2 cm, beginning at the tip of the right
limb. Each section was routinely processed, stained with hematoxylin and eosin (HE), and assessed with light microscopy by a single pathologist (SJN).
Hyperplastic foci were characterized as nodular to slightly
compressive, nonencapsulated masses of variable size (Fig.
1). Histologically, these hyperplastic foci were characterized
by aggregates of recognizable exocrine pancreatic epithelial
cells or, less commonly, ductular epithelial cells. Hyperplastic lesions were judged as being present or not and were
subsequently scored based on size and extent by a single
pathologist (SJN). Dogs were given a score of zero (no evidence of NH), one (less than 10% of the section showing
NH), two (10–40% of the section showing NH; Figs. 2 and
3), or three (greater than 40% of the section showing NH).
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Fig. 1. Pancreas; canine, dog 51. Multiple, pale, tan,
raised, discrete nodules are present on the pancreatic surface
(arrow).
A mean NH score was calculated by the sum of the scores
of all sections divided by the total number of sections evaluated. Age was recorded from the medical records for all
101 dogs. The mean age of the dogs was compared between
those with NH and those that had no evidence of this lesion
in any of the sections. Correlation of age and presence of
hyperplastic lesions was evaluated by the Spearman r-test in
all 101 dogs and also in a subgroup of 30 dogs that did not
have any evidence of pancreatic inflammation, necrosis, and/
or fibrosis. In addition, correlation of age and mean NH
score was evaluated by the Pearson r in both populations.
All statistical analyses were performed using a statistical
software package (Prism 4.0; GraphPad, San Diego, CA). A
P ⬍ 0.05 was considered statistically significant.
Hyperplastic foci were characterized as nodular to slightly
compressive, nonencapsulated masses of variable size that
only occasionally displayed peripheral fibrous connective
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tissue rimming. Additionally, inflammation, when associated
with the nodular lesions, was characterized by the presence
of minimal lymphocytes and fewer plasma cells. Histologically, these hyperplastic foci were characterized by tightly
packed aggregates of recognizable exocrine pancreatic epithelial cells arranged in acini or, less commonly, as ductular
epithelial cells.
Hyperplastic cells resembled the normal exocrine pancreatic epithelial cells, but occasionally, the cellular accumulation of zymogen granules was reduced in the hyperplastic
cells compared with those in the surrounding pancreatic tissues. Nuclear alterations were not apparent. Additionally,
there were no dogs with pancreatic nodular lesions that demonstrated dysplastic or neoplastic transformation (i.e., adenocarcinoma) in any of the multitude of examined sections.
Of the 101 dogs that underwent necropsy, 81 (80.2%) had
evidence of NH. Twenty-five of 101 dogs did not have any
evidence of pancreatic inflammation, necrosis, and/or fibrosis, of which 17 (68.0%) had NH. Mean ⫾ SD age of all
101 dogs was 8.3 ⫾ 4.2 years. Mean ⫾ SD age of dogs with
NH was significantly higher when compared with those dogs
without NH (9.5 ⫾ 3.4 years versus 3.4 ⫾ 3.3; P ⬍ 0.0001).
There was a positive correlation of age and presence of NH
in all 101 dogs (Spearman r ⫽ 0.5550; P ⬍ 0.0001) and in
the 25 dogs without any evidence of pancreatic inflammation, necrosis, and/or fibrosis (Spearman r ⫽ 0.6776; P ⬍
0.0002). Furthermore, there was a positive correlation between age and mean NH score in both groups of dogs (Pearson r ⫽ 0.6160 and 0.7104; P ⬍ 0.0001 and ⫽ 0.0001,
respectively; Figs. 4 and 5).
In the population of dogs examined here, NH was a very
common finding identified during necropsy (81/101 ⫽
80.2%). Also, the prevalence of this lesion increases with
age. Similarly, we have previously shown that pancreatic
inflammation, necrosis, and/or fibrosis is also a very common histopathologic finding in a similar population of dogs
presented for necropsy at the AMC (47/73 ⫽ 64.4%).8

Fig. 2. Pancreas; canine, dog 18. Multiple exocrine pancreatic hyperplastic nodules are present (asterisk*) and comprise
10–40% of this pancreas specimen, thus representing a grade II nodular hyperplasia. Hematoxylin and eosin. Bar ⫽ 317
m.
Fig. 3. Pancreas; canine, dog 18. Higher magnification of the area within the dashed box from Fig. 2 reveals a well
delineated nodule, composed of well-differentiated exocrine pancreatic epithelial cells, most of which contain lesser cytoplasmic zymogen stores than surrounding pancreatic acinar cells. Hematoxylin and eosin. Bar ⫽ 135 m.
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Fig. 4. Correlation of age and mean nodular hyperplasia
score in 101 dogs that underwent necropsy.
Fig. 5. Correlation of age and mean nodular hyperplasia
score in 25 dogs that underwent necropsy and did not have
any evidence of pancreatic inflammation, necrosis, and/or
fibrosis.
Exposure to traumatic injury or pancreatic inflammation/
necrosis would be expected to increase the longer an animal
lived. Similarly, if NH were a sequela to pancreatic inflammation or necrosis, a higher occurrence of pancreatic NH
could occur with advanced age. However, in approximately
21% (17/81) of our cases, the NH was not associated with
recognizable antecedent damage (fibrosis) or concurrent pancreatitis (necrosis or inflammation), despite evaluation of numerous samples. Mean NH shows a positive correlation with
age regardless of the presence or absence of pancreatic inflammation, necrosis, and/or fibrosis. Although hyperplasia
likely represents a method of tissue repair following pancreatic injury, our findings would suggest that this may not be
the only pathogenic mechanism for the development of NH.
None of the pancreatic hyperplastic nodular lesions demonstrated dysplastic or neoplastic transformation (i.e., adenocarcinoma) in any of the multitude of sections examined.
Although the size of individual nodules varied, the character
of the component cells did not vary from histologically normal exocrine pancreatic epithelial cells other than that, in
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some nodules, the increased number of compacted epithelial
cells was also often smaller and less eosinophilic because of
a lesser accumulation of cytoplasmic zymogen granules. The
hyperplastic epithelial cells respected the acinar arrangement
and nuclei were maintained in a basilar orientation. This
would suggest that NH is rarely a preneoplastic lesion in
dogs, despite its correlation with increasing age. Additionally, due to the relatively high frequency of pancreatic NH
lesions and the relative sparsity of pancreatic adenocarcinoma documented in the canine, these processes are determined to most likely be independent. Although adenocarcinoma is the most common exocrine pancreatic tumor in the
dog, the incidence is unreported but perceived as low. The
absence of a single case in our sample population of 101
dogs is thus not unexpected.
This correlation of NH and age would also appear to be
worth investigating in cats, where the presence of chronic
fibrosing pancreatitis is more commonly noted and might
result in a more consistent regenerative nodular tissue response in this species compared with the dog.4
Hepatic NH occurs in the liver of geriatric patients and is
interpreted typically as an incidental finding, the specific
cause of which is unknown.1 It is generally thought that hepatic NH is age related in dogs, as initial lesions are often
noted by 6–8 years of age and 70–100% of dogs will develop this condition by the time they are 14 years old.3 The
ability of the liver to be repaired by hyperplasia is well documented, and thus, these nodules could represent response
to injury, similar to what is seen with hepatic regenerative
nodules (hyperplasia of hepatocytes secondary to progressive fibrosis and destruction of hepatic parenchyma, such as
with cirrhosis).2 Similar to our findings in the exocrine pancreas, hepatic NH is also not considered preneoplastic.
Hyperplastic lesions seen in endocrine organs, such as in
adrenal or thyroid tissue, are capable of producing clinical
syndromes, such as hyperadrenocorticism (Cushing).6 These
hyperplastic changes are not considered a response to antecedent injury but are the result of chronic or persistent stimulation by high levels of pituitary hormones. For example,
high levels of adrenocorticotrophic hormone can stimulate
hyperplastic responses in the adrenal cortex, which are essentially reversible following removal of the stimulus. It is
only following neoplastic transformation of the highly proliferative cells that adrenal adenomas and adenocarcinoma
could result. We do not know if or how growth factors control exocrine pancreatic proliferation.
We do not know whether these exocrine pancreatic hyperplastic lesions are functional/secretory and serum testing
has not been performed. We hope to be able to correlate the
antemortem serum concentrations for various pancreatic
markers, specifically canine pancreatic lipase immunoreactivity, trypsin alpha 1 protease inhibitor, canine trypsinlike
immunoreactivity, amylase, and lipase to the histopathologic
findings in these dogs, in future studies. Canine pancreatic
lipase immunoreactivity may be the most sensitive and specific marker for exocrine pancreatic disease, yet its association with proliferative pancreatic lesions is undocumented.9
We conclude that NH of the exocrine pancreas occurs frequently in the dog and that the presence and severity of
lesions correlate with increasing age. Thus, NH is more com-
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mon in older dogs yet shows a positive correlation with age
regardless of the presence or absence of pancreatic inflammation, necrosis, and/or fibrosis.
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